These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23969185)

  • 41. Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.
    Gorsic LK; Kosova G; Werstein B; Sisk R; Legro RS; Hayes MG; Teixeira JM; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2862-2872. PubMed ID: 28505284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of gene polymorphisms in the anti-Müllerian hormone signalling pathway with ovarian function: a systematic review and meta-analysis.
    Cheng R; Xiong W; Luo X; Ma Y; Nie Y; Qiao X; Chen H; Hu Y; Xu L
    Reprod Biomed Online; 2019 Sep; 39(3):513-521. PubMed ID: 31253588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
    Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
    Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome.
    Du DF; Li XL; Fang F; Du MR
    Gynecol Endocrinol; 2014; 30(12):885-9. PubMed ID: 25170777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
    Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Bone Morphogenetic Protein 15 Up-Regulates the Anti-Müllerian Hormone Receptor Expression in Granulosa Cells.
    Pierre A; Estienne A; Racine C; Picard JY; Fanchin R; Lahoz B; Alabart JL; Folch J; Jarrier P; Fabre S; Monniaux D; di Clemente N
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2602-11. PubMed ID: 27070094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation of the effects of vitamin D treatment on the ovarian AMH receptors in a polycystic ovary syndrome experimental model: an ultrastructural and immunohistochemical study.
    Kuyucu Y; Sencar L; Tap Ö; Mete UÖ
    Reprod Biol; 2020 Mar; 20(1):25-32. PubMed ID: 31924508
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
    BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.
    Kordestani F; Mazloomi S; Mortazavi Y; Mazloomzadeh S; Fathi M; Rahmanpour H; Nazarian A
    BMC Med Genet; 2018 Aug; 19(1):149. PubMed ID: 30134857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
    Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
    J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect Modification of LHCGR Gene Variant (rs2293275) on Clinico-Biochemical Profile, and Levels of Luteinizing Hormone in Polycystic Ovary Syndrome Patients.
    Makhdoomi MJ; Shah IA; Rashid R; Rashid A; Singh S; Shah ZA; Ganie MA
    Biochem Genet; 2023 Aug; 61(4):1418-1432. PubMed ID: 36633772
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity.
    Kevenaar ME; Themmen AP; Rivadeneira F; Uitterlinden AG; Laven JS; van Schoor NM; Lips P; Pols HA; Visser JA
    Hum Reprod; 2007 Sep; 22(9):2382-8. PubMed ID: 17636279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutational Analysis of the Putative Anti-Müllerian Hormone (AMH) Binding Interface on its Type II Receptor, AMHR2.
    Hart KN; Pépin D; Czepnik M; Donahoe PK; Thompson TB
    Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32333774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome.
    Czeczuga-Semeniuk E; Jarząbek K; Galar M; Kozłowski P; Sarosiek NA; Zapolska G; Wołczyński S
    Endocrine; 2015 Apr; 48(3):1001-4. PubMed ID: 25012254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.